163 related articles for article (PubMed ID: 29046325)
1. Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study.
Wijnen M; Olsson DS; van den Heuvel-Eibrink MM; Hammarstrand C; Janssen JAMJL; van der Lely AJ; Johannsson G; Neggers SJCMM
Eur J Endocrinol; 2018 Jan; 178(1):93-102. PubMed ID: 29046325
[TBL] [Abstract][Full Text] [Related]
2. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.
Olsson DS; Andersson E; Bryngelsson IL; Nilsson AG; Johannsson G
J Clin Endocrinol Metab; 2015 Feb; 100(2):467-74. PubMed ID: 25375987
[TBL] [Abstract][Full Text] [Related]
3. Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study.
Olsson DS; Bryngelsson IL; Ragnarsson O
Eur J Endocrinol; 2016 Jul; 175(1):55-61. PubMed ID: 27147638
[TBL] [Abstract][Full Text] [Related]
4. Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement.
Yuen KCJ; Mattsson AF; Burman P; Erfurth EM; Camacho-Hubner C; Fox JL; Verhelst J; Geffner ME; Abs R
J Clin Endocrinol Metab; 2018 Feb; 103(2):768-777. PubMed ID: 29029108
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.
Hammarstrand C; Ragnarsson O; Bengtsson O; Bryngelsson IL; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 Oct; 179(4):229-237. PubMed ID: 30299891
[TBL] [Abstract][Full Text] [Related]
6. Excess mortality after craniopharyngioma treatment: are we making progress?
Qiao N
Endocrine; 2019 Apr; 64(1):31-37. PubMed ID: 30569259
[TBL] [Abstract][Full Text] [Related]
7. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.
Tomlinson JW; Holden N; Hills RK; Wheatley K; Clayton RN; Bates AS; Sheppard MC; Stewart PM
Lancet; 2001 Feb; 357(9254):425-31. PubMed ID: 11273062
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.
Pereira AM; Schmid EM; Schutte PJ; Voormolen JH; Biermasz NR; van Thiel SW; Corssmit EP; Smit JW; Roelfsema F; Romijn JA
Clin Endocrinol (Oxf); 2005 Feb; 62(2):197-204. PubMed ID: 15670196
[TBL] [Abstract][Full Text] [Related]
9. Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study.
Olsson DS; Nilsson AG; Bryngelsson IL; Trimpou P; Johannsson G; Andersson E
J Clin Endocrinol Metab; 2015 Jul; 100(7):2651-8. PubMed ID: 25946030
[TBL] [Abstract][Full Text] [Related]
10. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence.
Bülow B; Attewell R; Hagmar L; Malmström P; Nordström CH; Erfurth EM
J Clin Endocrinol Metab; 1998 Nov; 83(11):3897-904. PubMed ID: 9814465
[TBL] [Abstract][Full Text] [Related]
11. Morbidity and mortality in patients with craniopharyngioma after surgery.
Crowley RK; Hamnvik OP; O'Sullivan EP; Behan LA; Smith D; Agha A; Thompson CJ
Clin Endocrinol (Oxf); 2010 Oct; 73(4):516-21. PubMed ID: 20550527
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk profile in growth hormone-treated adults with craniopharyngioma compared to non-functioning pituitary adenoma: a national cohort study.
Verweij T; Slagboom TNA; van Varsseveld NC; van der Lely AJ; Drent ML; van Bunderen CC
Eur J Endocrinol; 2021 Oct; 185(6):793-801. PubMed ID: 34605771
[TBL] [Abstract][Full Text] [Related]
13. Mortality in adults with hypopituitarism: a systematic review and meta-analysis.
Jasim S; Alahdab F; Ahmed AT; Tamhane S; Prokop LJ; Nippoldt TB; Murad MH
Endocrine; 2017 Apr; 56(1):33-42. PubMed ID: 27817141
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Endocrine and Metabolic Comorbidities in a National Cohort of Patients with Craniopharyngioma.
Jazbinšek S; Kolenc D; Bošnjak R; Faganel Kotnik B; Zadravec Zaletel L; Jenko Bizjan B; Vipotnik Vesnaver T; Battelino T; Janež A; Jensterle M; Kotnik P
Horm Res Paediatr; 2020; 93(1):46-57. PubMed ID: 32460296
[TBL] [Abstract][Full Text] [Related]
15. Mortality and cancer incidence among individuals with Down syndrome.
Hill DA; Gridley G; Cnattingius S; Mellemkjaer L; Linet M; Adami HO; Olsen JH; Nyren O; Fraumeni JF
Arch Intern Med; 2003 Mar; 163(6):705-11. PubMed ID: 12639204
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up.
Wijnen M; Olsson DS; van den Heuvel-Eibrink MM; Hammarstrand C; Janssen JAMJL; van der Lely AJ; Johannsson G; Neggers SJCMM
Eur J Endocrinol; 2018 Jan; 178(1):11-22. PubMed ID: 28882980
[TBL] [Abstract][Full Text] [Related]
17. Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden.
Tanash HA; Ekström M; Wagner P; Piitulainen E
Int J Chron Obstruct Pulmon Dis; 2016; 11():1663-9. PubMed ID: 27555756
[TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49).
Schrijnders D; Hendriks SH; Kleefstra N; Vissers PAJ; Johnson JA; de Bock GH; Bilo HJG; Landman GWD
PLoS One; 2018; 13(1):e0190870. PubMed ID: 29370205
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Mortality Risks of Cancer in Patients with Type 2 Diabetes: A Retrospective Study in Shanghai, China.
Gu Y; Hou X; Zheng Y; Wang C; Zhang L; Li J; Huang Z; Han M; Bao Y; Zhong W; Jia W; Cui S
Int J Environ Res Public Health; 2016 Jun; 13(6):. PubMed ID: 27271648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
